Drugs.com - Pharma Industry News

Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer

THURSDAY, May 8, 2025 -- Ultra-hypofractionated (UHF) radiotherapy delivered over two weeks is noninferior to conventionally fractionated (CF) radiotherapy delivered over eight weeks for localized prostate cancer up to 10 years, according to a...

May 8, 2025 - 19:01
 0
Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
THURSDAY, May 8, 2025 -- Ultra-hypofractionated (UHF) radiotherapy delivered over two weeks is noninferior to conventionally fractionated (CF) radiotherapy delivered over eight weeks for localized prostate cancer up to 10 years, according to a...
Read More

Tags:

Previous Article

Intangible Assets in Hotel Property Tax Assessments & By Bryan Younge

Next Article

False-Negative Rate High for Seated Saline Suppression Test for Primary Aldoster...

Related Posts

Targeted Grant Terminations Have Affected 694 NIH Grants

Targeted Grant Terminations Have Affected 694 NIH Grants

May 9, 2025  0

Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women

Hormone Therapy Tied to Worse Bladder Health in Postmen...

May 6, 2025  0

One in 10 U.S. Internal Medicine Doctors Report High Degree of Burnout

One in 10 U.S. Internal Medicine Doctors Report High De...

May 6, 2025  0